Read the article
The Flash Glucose Monitoring (FGM) -based program enables BeatO members to gain actionable insights from the BeatO team of experts based on ongoing data from the Flash Glucose Monitor.
With the increasing number of complications resulting from uncontrolled diabetes, BeatO yesterday announced the introduction of a flash glucose monitoring program for better data-driven prevention, control and reversal of diabetes. This enables users to better assess their nutritional relationships and to receive targeted nutrition, life and dosage advice from a team of BeatO doctors and experts based on FGM data.
The flash blood glucose meter is located behind the upper arm and uses a sensor that the user wears externally. This is a great way to monitor your blood glucose data with the FGM reader. FGM data enables BeatO health workers to monitor trends and provide patient-specific insights to achieve targeted HbA1c levels. BeatO added a statement that it plans to use Abbott’s FGM device.
The current scenario of COVID-19 also states that elevated blood sugar levels and the development of diabetes have been observed as sequelae during recovery from COVID-19. Post-COVID complications such as zygomycosis have also increased significantly in recent weeks due to uncontrolled diabetes, among other things. In addition, timely counseling and treatment accelerated recovery from COVID, while in other cases recovery was delayed by up to 3 months. This requires continuous monitoring and accurate decision-making about foods, lifestyles, and medications based on blood sugar levels. Continuous feedback from BeatO’s in-house nutrition analysts, trainers, and doctors based on your dynamic glucose levels can improve blood sugar control and prevent complications that arise from your condition.
Commenting on the announcement, BeatO co-founder and CEO Gautam Chopra said: Diabetes. Our FGM-enabled program is an extension of our vision to provide members with appropriate decision support for their health. “
This integration of FGM and BeatO’s app ecosystem enables users to understand the relationship of foods to glucose fluctuations such as hypoglycemia and hyperglycemia and to better manage their overall health. Patient management becomes possible. BeatO, one of India’s largest digital health platforms for chronic diseases, offers users effective, evidence-based insights based on blood sugar measurements.
BeatO Launches Flash Glucose Monitoring Program For Diabetes Prevention, Control, And Reversal Source link BeatO Launches Flash Glucose Monitoring Program For Diabetes Prevention, Control, And Reversal
